http://www.marketwatch.com/story/inovio-initiates-h1n1-universal-influenza-vaccine-clinical-trial-targeting-over-65-population-which-represents-90-of-flu-deaths-2012-07-10
Posted by Rob LW
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment